Sarcopenia and age-related endocrine function.

Area of Science:

• Gerontology
• Endocrinology
• Muscle Physiology

Background:

• Sarcopenia is the age-related loss of skeletal muscle mass and function.
• It leads to reduced mobility, decreased strength, and increased fall risk.
• Molecular mediators of sarcopenia present drug discovery targets.

Purpose of the Study:

• To review the endocrine factors contributing to sarcopenia.
• To update on hormonal interventions for sarcopenia.
• To explore potential therapeutic strategies for age-related muscle loss.

Main Methods:

• Literature review of endocrine contributions to sarcopenia.
• Analysis of hormonal interventions, including myostatin inhibition, testosterone, IGF-I, and ghrelin.
• Discussion of vitamin D's role in sarcopenia prevention.

Main Results:

• Myostatin inhibition is a promising strategy, alongside resistance training and amino acid supplementation.
• Testosterone supplementation can improve muscle defects but has side effects.
• Ghrelin may counteract age-related muscle atrophy and is orally active.
• IGF-I therapeutic use is limited by local resistance.
• Further research on vitamin D mechanisms is needed for sarcopenia prevention.

Conclusions:

• Hormonal interventions offer potential therapeutic avenues for sarcopenia.
• Myostatin inhibition and ghrelin present promising strategies.
• Understanding endocrine defects is crucial for developing effective sarcopenia treatments.